An automated system for detecting nonadherence in laboratory testing and monitoring for myelosuppression in patients receiving self-administered oral chemotherapy

Journal of Oncology Practice

Volumn 9, Issue 5, 2013, Pages

  Morrell, Robert M ^a   Tooze, Janet A ^a   Harmon, Michele S ^a   Carter, Annette F ^a   DeTroye, Alisha T ^a   Lesser, Glenn J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE;

ADULT; AUTOMATION; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER PATIENT; COMPUTER PROGRAM; DRUG SELF ADMINISTRATION; FEMALE; GLIOBLASTOMA; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT MONITORING; RETROSPECTIVE STUDY; REVIEW;

ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BLOOD CELL COUNT; BRAIN NEOPLASMS; CLINICAL LABORATORY SERVICES; DACARBAZINE; FEMALE; GLIOBLASTOMA; HEMATOLOGIC DISEASES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SELF ADMINISTRATION; SOFTWARE;

EID: 84892563967     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2012.000834     Document Type: Review

References (13)

1. Toma S, Palumbo R, Rosso R: Results, toxicity and compliance in chemoprevention trials of head and neck cancer. Eur J Cancer Prev 3: 63-68, 1994 (Pubitemid 24062666)
2. Foulon V, Schöffski P, Wolter P: Patient adherence to oral anticancer drugs: An emerging issue in modern oncology. Acta Clin Belg 66: 85-96, 2011
3. Hénin E, Tod M, Trillet-Lenoir V, et al: Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: In silico evaluation. Clin Pharmacokinet 48: 359-369, 2009
4. Winkeljohn D: Adherence to oral cancer therapies: Nursing interventions. Clin J Oncol Nurs 14: 461-466, 2010
5. Maloney KW, Kagan SH: Adherence and oral agents with older patients. Semin Oncol Nurs 27: 154-160, 2011
6. Phillips B, Richards M, Boys R, et al: A home-based maintenance therapy program for acute lymphoblastic leukemia - Practical and safe? J Pediatr Hematol Oncol 33: 433-436, 2011
7. Stupp P, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005 (Pubitemid 40349501)
8. Liu R, Wang X, Ma B, et al: Concomitant or adjuvant temozolomide with whole-brain irradiation for brain metastases: A meta-analysis. Anticancer Drugs 21: 120-128, 2010
9. Gerber DE, Grossman SA, Zeltzman M, et al: The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas. Neuro Oncol 9: 47-52, 2007 (Pubitemid 46543488)
10. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS. March 31, 2003. Publish Date: August 9, 2006
11. Morrell R, Wasilauskas B, Winslow R: Personal computer-based expert system for quality assurance of antimicrobial therapy. Am J Hosp Pharm 50:2067- 2073, 1993 (Pubitemid 23298172)
12. Toussi M, Choleau C, Reach G, et al: A novel method for measuring patient's adherence to insulin dosing guidelines: Introducing indicators of adherence. BMC Med Inform Decis Mak 8:55, 2008
13. Shiff GD, Bates DW: Can electronic clinical documentation help prevent diagnostic errors? N Engl J Med 362: 1066-1069, 2010